Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about CymaBay-2023-09-13
$258.7 Million
Image
CymaBay Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about Crinetics-2023-09-12
$350.0 Million
Image
Crinetics Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about Biohaven Ltd.-2023-10-02
$258.7 Million
Image
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ALX Oncology-2023-10-04
$63.2 Million
Image
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Gladstone-2023-08-10
$57.0 Million
Image
Gladstone Capital Corporation
Senior Notes Offering
Left Bookrunner
Read more
about Arhaus-2023-08-16
$138.0 Million
Image
Arhaus, LLC
Follow-On Offering
Active Bookrunner
Read more
about Inozyme-2023-07-27
$60.0 Million
Image
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Procept-2023-08-01
$149.9 Million
Image
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about BlackDiamondTherapeutics-2023-06-29
$75.0 Million
Image
Black Diamond Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about Savers-2023-06-28
$461.4 Million
Image
Savers, Inc.
Initial Public Offering
Passive Bookrunner
Pagination
Previous page
‹‹
Page 23
Next page
››
Subscribe to Equity Capital Markets
